Avoro Capital Advisors is a global life sciences investment firm.
Business Model:
Revenue: $0
Employees: 0-0
Address: 110 Greene Street
City: New York
State: NY
Zip: 10012
Country: US
Avoro Capital Advisors is a global life sciences investment firm with a focus on supporting emerging biotechnology companies. Formerly known as venBio Select Advisor, ITwas established in 2010 and is headquartered in New York, United States.
Contact Phone:
+12129374970
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
2/2021 | Vividion Therapeutics | Series C | 135M |
4/2020 | Mersana Therapeutics | Post-IPO Equity | 0 |
8/2020 | PMV Pharmaceuticals | Series D | 70M |
8/2021 | Tango Therapeutics | Post-IPO Equity | 0 |
3/2021 | Scribe Therapeutics | Series B | 100M |
8/2022 | Kymera Therapeutics | Post-IPO Equity | 150M |
1/2021 | IO Biotech | Series B | 0 |
3/2021 | Monte Rosa Therapeutics | Series C | 0 |
7/2020 | Praxis Precision Medicines | Series C | 0 |
1/2021 | Design Therapeutics | Series B | 125M |
5/2021 | Nuvalent | Series B | 0 |
9/2022 | Aadi | Post-IPO Equity | 72.5M |
10/2020 | Olema Oncology | Series C | 85M |
8/2021 | Tango Therapeutics | Post-IPO Equity | 0 |
5/2021 | Nuvalent | Series B | 0 |
3/2021 | Scribe Therapeutics | Series B | 0 |
3/2021 | Monte Rosa Therapeutics | Series C | 0 |
2/2021 | Vividion Therapeutics | Series C | 0 |
1/2021 | Design Therapeutics | Series B | 0 |
1/2021 | IO Biotech | Series B | 0 |
10/2020 | Olema Oncology | Series C | 0 |
8/2020 | PMV Pharmaceuticals | Series D | 0 |
7/2020 | Praxis Precision Medicines | Series C | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|